182 related articles for article (PubMed ID: 34673590)
21. Transducer-like enhancer of split 1 (TLE1) expression as a diagnostic immunohistochemical marker for synovial sarcoma and its association with morphological features.
Bakrin IH; Hussain FA; Tuan Sharif SE
Malays J Pathol; 2016 Aug; 38(2):117-22. PubMed ID: 27568668
[TBL] [Abstract][Full Text] [Related]
22. MDM2 amplification and fusion gene ss18-ssx in a poorly differentiated synovial sarcoma: A rare but puzzling conjunction.
Di Mauro I; Mescam-Mancini L; Chetaille B; Lae M; Pierron G; Dadone-Montaudie B; Bazin A; Bouvier C; Michiels JF; Pedeutour F
Neoplasia; 2020 Aug; 22(8):311-321. PubMed ID: 32559641
[TBL] [Abstract][Full Text] [Related]
23. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases.
Knösel T; Heretsch S; Altendorf-Hofmann A; Richter P; Katenkamp K; Katenkamp D; Berndt A; Petersen I
Eur J Cancer; 2010 Apr; 46(6):1170-6. PubMed ID: 20189377
[TBL] [Abstract][Full Text] [Related]
24. [Expression of SS18-SSX fusion-specific antibody and SSX C-terminal antibody in synovial sarcoma and its diagnostic value].
Wang X; Cheng K; Wu N; Li R; Chen H; Ma HH; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):740-744. PubMed ID: 34405607
[No Abstract] [Full Text] [Related]
25. [Clinicopathological analysis of 12 cases of children synovial sarcoma].
Liu YF; Jia C; Zhang M; Chen GS; Zhang N; Fu LB; Wang L; He LJ
Zhonghua Bing Li Xue Za Zhi; 2019 Sep; 48(9):705-709. PubMed ID: 31495091
[No Abstract] [Full Text] [Related]
26. Histology and grading are important prognostic factors in synovial sarcoma.
Bianchi G; Sambri A; Righi A; Dei Tos AP; Picci P; Donati D
Eur J Surg Oncol; 2017 Sep; 43(9):1733-1739. PubMed ID: 28579008
[TBL] [Abstract][Full Text] [Related]
27. Reappraisal of TLE-1 immunohistochemical staining and molecular detection of SS18-SSX fusion transcripts for synovial sarcoma.
Chuang HC; Hsu SC; Huang CG; Hsueh S; Ng KF; Chen TC
Pathol Int; 2013 Dec; 63(12):573-80. PubMed ID: 24422953
[TBL] [Abstract][Full Text] [Related]
28. The diagnostic value of SYT-SSX detected by reverse transcriptase-polymerase chain reaction (RT-PCR) and fluorescence in situ hybridization (FISH) for synovial sarcoma: a review and prospective study of 255 cases.
Sun B; Sun Y; Wang J; Zhao X; Zhang S; Liu Y; Li X; Feng Y; Zhou H; Hao X
Cancer Sci; 2008 Jul; 99(7):1355-61. PubMed ID: 18460022
[TBL] [Abstract][Full Text] [Related]
29. Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma.
Mihály D; Nagy N; Papp G; Pápai Z; Sápi Z
Diagn Pathol; 2018 Oct; 13(1):81. PubMed ID: 30326929
[TBL] [Abstract][Full Text] [Related]
30. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
[TBL] [Abstract][Full Text] [Related]
31. The Utility of NKX2.2 and TLE1 Immunohistochemistry in the Differentiation of Ewing Sarcoma and Synovial Sarcoma.
Rooper LM; Sharma R; Gocke CD; Belchis DA
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):174-179. PubMed ID: 28800015
[TBL] [Abstract][Full Text] [Related]
32. Interdependence of SS18-SSX-driven YAP1 and β-Catenin Activation in Synovial Sarcoma.
Isfort I; Berthold R; Heinst L; Wardelmann E; Larsson O; Trautmann M; Hartmann W
Mol Cancer Res; 2023 Jun; 21(6):535-547. PubMed ID: 36920288
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical validation of INI1/SMARCB1 in a spectrum of musculoskeletal tumors: an experience at a Tertiary Cancer Referral Centre.
Rekhi B; Jambhekar NA
Pathol Res Pract; 2013 Dec; 209(12):758-66. PubMed ID: 24075062
[TBL] [Abstract][Full Text] [Related]
34. Synovial Sarcoma of the Gastrointestinal Tract.
Ortiz Requena D; Longacre TA; Rosenberg AE; Velez Torres JM; Yanchenko N; Garcia-Buitrago MT; Voltaggio L; Montgomery EA
Mod Pathol; 2024 Jan; 37(1):100383. PubMed ID: 37972927
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic utility of dual-color break-apart chromogenic in situ hybridization for the detection of rearranged SS18 in formalin-fixed, paraffin-embedded synovial sarcoma.
Motoi T; Kumagai A; Tsuji K; Imamura T; Fukusato T
Hum Pathol; 2010 Oct; 41(10):1397-404. PubMed ID: 20594581
[TBL] [Abstract][Full Text] [Related]
36. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms.
Kosemehmetoglu K; Vrana JA; Folpe AL
Mod Pathol; 2009 Jul; 22(7):872-8. PubMed ID: 19363472
[TBL] [Abstract][Full Text] [Related]
37. Adamantinoma with a Prominent Spindle Cell Component Mimicking Intraosseous Synovial Sarcoma: Clinicopathological Features of Six Tumors.
Rekhi B; Yildiz AE; Jennifer A; Yukruk FA; Gedikoglu G; Banerjee D; Shetty O; Kosemehmetoglu K
Int J Surg Pathol; 2022 Dec; 30(8):872-884. PubMed ID: 35946120
[No Abstract] [Full Text] [Related]
38. [Primary synovial sarcoma of lung: a clinicopathological analysis of 12 cases].
Zhang XW; Wei JG; Sun JP; Xu ZG; Cheng Q; Zhang L; Kong LF
Zhonghua Bing Li Xue Za Zhi; 2023 Nov; 52(11):1120-1125. PubMed ID: 37899317
[No Abstract] [Full Text] [Related]
39. Paracrine osteoprotegerin and β-catenin stabilization support synovial sarcomagenesis in periosteal cells.
Barrott JJ; Illum BE; Jin H; Hedberg ML; Wang Y; Grossmann A; Haldar M; Capecchi MR; Jones KB
J Clin Invest; 2018 Jan; 128(1):207-218. PubMed ID: 29202462
[TBL] [Abstract][Full Text] [Related]
40. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study.
Ito J; Asano N; Kawai A; Yoshida A
Hum Pathol; 2016 Jan; 47(1):32-7. PubMed ID: 26520417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
